Genetically heterogeneous glioblastoma recurring with disappearance of 1p/19q losses: Case report

Neurosurgery

Volumn 61, Issue 1, 2007, Pages

  Ito, Motokazu ^a   Wakabayashi, Toshihiko ^b   Natsume, Atsushi ^b   Hatano, Hisashi ^a   Fujii, Masazumi ^a   Yoshida, Jun ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Glioblastoma; Heterogeneity; Loss of heterozygosity; Recurrence

Indexed keywords

BETA INTERFERON; RANIMUSTINE;

ADULT; ALLELE; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CASE REPORT; CELL CULTURE; CHEMOSENSITIVITY; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME LOSS; CRANIOTOMY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GENETIC ANALYSIS; GLIOBLASTOMA; HEADACHE; HETEROZYGOSITY LOSS; HUMAN; PRIORITY JOURNAL; TUMOR RECURRENCE; VISUAL DISORDER; CHROMOSOME 1; CHROMOSOME 19; CHROMOSOME DISORDER; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

BRAIN NEOPLASMS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; CRANIOTOMY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLIOBLASTOMA; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL;

EID: 34547630097     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.neu.0000279739.53425.5c     Document Type: Article

References (15)

1. Branle F, Lefranc F, Camby I, Jeuken J, Geurts-Moespot A, Sprenger S, Sweep F, Kiss R, Salmon I: Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy. Cancer 95:641-655, 2002.
2. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473-1479, 1998.
3. Coons SW, Johnson PC: Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index. J Neuropathol Exp Neurol 52:609-618, 1993.
4. Fuller GN, Mircean C, Tabus I, Taylor E, Sawaya R, Bruner JM, Shmulevich I, Zhang W: Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression. Oncol Rep 14:651-656, 2005.
5. Goldman S, Levivier M, Pirotte B, Brucher JM, Wikler D, Damhaut P, Stanus E, Brotchi J, Hildebrand J: Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy. Cancer 78:1098-1106, 1996.
6. Gottesman MM, Fojo T, Bates SE: Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat Rev Cancer 2:48-58, 2002.
7. Hulsebos TJ, Troost D, Leenstra S: Molecular-genetic characterisation of gliomas that recur as same grade or higher grade tumours. J Neurol Neurosurg Psychiatry 75:723-726, 2004.
8. Ino Y, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Jhung S, Ramsay DA, von Deimling A, Louis DN, Cairncross JG: Long survival and therapeutic responses in patients with histologically disparate highgrade gliomas demonstrating chromosome 1p loss. J Neurosurg 92:983-990, 2000.
9. Kondo T: Brain cancer stem-like cells. Eur J Cancer 42:1237-1242, 2006.
10. Paulus W, Peiffer J: Intratumoral histologic heterogeneity of gliomas. Aquantitative study. Cancer 64:442-447, 1989.
11. Reifenberger G, Bilzer T, Seitz RJ, Wechsler W: Expression of vimentin and glial fibrillary acidic protein in ethylnitrosourea-induced rat gliomas and glioma cell lines. Acta Neuropathol (Berl) 78:270-282, 1989.
12. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B: Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355:846-847, 1992.
13. Terada K, Tamiya T, Daido S, Kambara H, Tanaka H, Ono Y, Matsumoto K, Ito S, Ouchida M, Ohmoto T, Shimizu K: Prognostic value of loss of heterozygosity around three candidate tumor suppressor genes on chromosome 10q in astrocytomas. J Neurooncol 58:107-114, 2002.
14. Wolf HK, Buslei R, Blumcke I, Wiestler OD, Pietsch T: Neural antigens in oligodendrogliomas and dysembryoplastic neuroepithelial tumors. Acta Neuropathol (Berl) 94:436-443, 1997.
15. Zlatescu MC, TehraniYazdi A, Sasaki H, Megyesi JF, Betensky RA, Louis DN, Cairncross JG: Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res 61:6713-6715, 2001.